No CrossRef data available.
Published online by Cambridge University Press: 31 July 2026
Substance use disorders (SUDs) are often associated with other mental disorders—psychotic, mood, or anxiety—complicating treatment and worsening clinical and social outcomes.
To describe the main psychiatric comorbidities among patients with SUDs and examine their relationship with substance type.
A retrospective descriptive study based on clinical records of patients consulting for SUDs. Collected data included sociodemographic profile, substances used, psychiatric diagnoses, and treatments.
Results (N = 102):
- Gender: predominantly male (~90%).
- Age: mostly 20–40 years.
- Main substances: tobacco (85%), cannabis (70%), alcohol (56%).
- Comorbid disorders: psychotic (45%), mood (30%), anxiety (15%), personality (10%).
- Polysubstance use: >50% of patients.
- Treatments: antipsychotics (79%), antidepressants (55%), anxiolytics (38%).
SUDs are commonly associated with severe psychiatric comorbidities. Systematic screening and a dual-diagnosis approach are key to enhancing prognosis and patient reintegration.
None Declared
Comments
No Comments have been published for this article.